Virginia is where this series began. The first Patients Rising case posts in the Medical Bankruptcy in America series were Virginia cases. The first hospital-systems analysis we published — identifying Sentara, Bon Secours, Centra, Mary Washington, Carilion, and Inova as the most frequently appearing creditors on Virginia bankruptcy schedules — drew on Virginia data.
We have now applied the same methodology to five more states: Colorado, Louisiana, Maine, Washington, and Wisconsin. Returning to Virginia in light of that broader pattern, the state turns out to be distinct in a specific way:
Virginia is the largest-volume state in the series, and it accounts for more verified 340B hospital debt than any of the other five states.
Across 275 Chapter 7 and Chapter 13 individual bankruptcy filings from the Eastern and Western Districts of Virginia, January through May 2024:
For context: the next-largest verified 340B dollar total in the series is Wisconsin's $1.16 million. Virginia's total is nearly twice that, accumulated in five months.
Sentara Healthcare and Bon Secours Mercy Health together account for more than a third of the 275 filings.
Sentara, headquartered in Norfolk, operates the dominant hospital network across Hampton Roads — Norfolk General, Leigh, CarePlex Hampton, Princess Anne, Virginia Beach General, Williamsburg — plus Sentara RMH in Harrisonburg, Sentara Martha Jefferson in Charlottesville, Sentara Northern Virginia in Woodbridge, and Sentara Halifax in South Boston. All major Sentara hospitals are 340B-participating disproportionate-share hospitals. The system appears on 42 of the 275 cases for a total of $507,428 — the highest dollar volume of any single creditor in the dataset.
Bon Secours Mercy Health, the Catholic system covering both Hampton Roads (Maryview Portsmouth, DePaul Norfolk, Mary Immaculate Newport News) and Richmond (St. Mary's, Memorial Regional Mechanicsville, St. Francis Midlothian, Richmond Community, Southside Petersburg), appears on 54 cases for $367,438. All major facilities are 340B DSH.
Add the third- and fourth-largest creditors — Centra Health (32 cases, $160,885) and Mary Washington Healthcare (24 cases, $419,848) — and four systems account for 152 of 275 cases and $1,455,599, or sixty-seven percent of all verified 340B debt in the dataset.
The remaining 340B debt is distributed across Inova, Carilion, Ballad, Riverside, Valley Health, Augusta, UVA, VCU/MCV, Chesapeake Regional, Children's Hospital of The King's Daughters, and a handful of independent and critical-access hospitals across the state.
The for-profit, non-340B hospital systems — HCA Virginia (Henrico Doctors', Chippenham, Johnston-Willis, LewisGale Salem and its sister facilities, Reston, StoneSprings, Spotsylvania) and Lifepoint (SOVAH Danville and SOVAH Martinsville) — do appear on Virginia bankruptcy schedules. But in lower aggregate dollars than the nonprofit 340B systems, and they are correctly excluded from the $2.15M total.
The single largest 340B hospital balance we have found in any of the six state datasets sits on a Fredericksburg schedule.
A household in the Fredericksburg metropolitan area filed joint Chapter 7 in February 2024. Their schedules list $478,313 in total liabilities, of which $379,261 — eighty-one percent of unsecured debt — is medical. The bulk of that medical debt, $376,855, is owed to Mary Washington Healthcare across multiple separate balances. The household's monthly income, by Schedule I, was $5,160. Their monthly expenses ran $5,426. Their margin, before any payment on the bankruptcy debt: negative $266 a month.
What the schedule shows is not a single $376,855 hospital bill. It is the pattern Patients Rising has flagged before: medical debt that accumulates across a single regional hospital system in pieces that appear separate on the schedule but financially aggregate into a number that few American households could absorb.
Mary Washington Healthcare is a 340B disproportionate-share hospital. Its two facilities — Mary Washington Hospital and Stafford Hospital — provide most inpatient care for roughly 350,000 area residents. The system's federal Form 990 reports total annual revenues exceeding $700 million. Its 340B drug-pricing savings, by industry estimates for systems of its size, are typically in the eight-figure range annually.
That single household's balance is roughly twenty percent of the total verified 340B debt in our entire 275-case Virginia dataset.
Across the six state datasets:
| State | Cases | Window | % medical | % 340B | Verified 340B $ |
|---|---|---|---|---|---|
| Virginia | 275 | 5 mo (Jan–May 2024) | 89% | 53% | $2,154,860 |
| Wisconsin | 104 | 2 mo (Jan–Feb 2024) | 92% | 65% | $1,160,048 |
| Washington | 146 | 8 mo (Jan–Aug 2024) | 81% | 35% | $1,044,903 |
| Louisiana | 130 | 8 mo (Jan-May 2024) | 85% | 50% | $930,000 |
| Colorado | 187 | 8 mo (Jan-May 2024) | 86% | 52% | $890,000 |
| Maine | 61 | 8 mo (Jan-May 2024) | 80% | 52% | $326,241 |
Wisconsin has the highest 340B exposure rate of any state at 65 percent. Maine has the most concentrated rural-hospital dependency. Washington's total is dominated by a handful of very large single-event balances. Louisiana has the single most striking individual case profile.
What distinguishes Virginia is volume and geographic breadth. 275 cases, distributed across all eleven of the state's congressional districts, intersecting with at least twelve major 340B hospital systems. The dataset documents medical bankruptcy in Tidewater (Sentara), Richmond (Bon Secours and VCU Health), Fredericksburg (Mary Washington's single-system dominance), Lynchburg and Danville (Centra), Roanoke and Southwest Virginia (Carilion and Ballad), the Shenandoah Valley (Augusta, Valley Health, Sentara RMH), and Northern Virginia (Inova).
In each region the same basic pattern appears: working- and middle-class households, often joint filers, with medical debt accumulated across one or two or three nonprofit hospital systems — all of which participate in 340B.
Virginia's 340B-participating hospitals receive substantial drug-pricing discounts under the federal program. Industry estimates place the aggregate Virginia 340B savings at more than $500 million annually. Those discounts flow into hospital pharmacy budgets, where, per HRSA rules, they are supposed to support patient care for the populations whose existence justifies the discounts.
The Virginia Hospital and Healthcare Association does not publish, in any reporting we have located, a state-level tally of patient bills owed by patients who subsequently declared bankruptcy. That number is not, by any federal or state regulation, required to be reported.
The 275 cases in this dataset — 146 of them with verified 340B hospital creditor lines, totaling $2,154,860 in a five-month window — represent the patient-side ledger of that unreported metric. Annualized, the pipeline accounts for roughly $5.2 million in 340B medical-bankruptcy debt from Virginia alone. The full universe of Virginia medical bankruptcies, including cases not in our referral pipeline, would be substantially larger.
The Virginia hospital systems continue to receive federal 340B drug-pricing benefits without conditioning those benefits on patient-side cost reduction. The patients continue to appear in federal bankruptcy court. The program's statutory design and the patients' financial reality coexist in the same dataset.
Virginia is the first chapter of this series and, by these numbers, the heaviest. State-level pieces and individual case posts for Colorado, Louisiana, Maine, Washington, and Wisconsin will follow in the coming weeks. Each shows the same basic pattern — verified 340B hospital debt as a substantial share of consumer bankruptcy filings — with its own structural variation.
The headline finding across all six states: roughly $6.5 million in verified 340B hospital debt across approximately 900 individual bankruptcy filings, with the largest single balance in the entire series sitting on a Fredericksburg schedule.
Methodology and aggregate data tables available on request.